Sullivan Km

920 total citations
20 papers, 707 citations indexed

About

Sullivan Km is a scholar working on Hematology, Surgery and Emergency Medicine. According to data from OpenAlex, Sullivan Km has authored 20 papers receiving a total of 707 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 3 papers in Surgery and 3 papers in Emergency Medicine. Recurrent topics in Sullivan Km's work include Hematopoietic Stem Cell Transplantation (15 papers), Hematological disorders and diagnostics (3 papers) and Transplantation: Methods and Outcomes (3 papers). Sullivan Km is often cited by papers focused on Hematopoietic Stem Cell Transplantation (15 papers), Hematological disorders and diagnostics (3 papers) and Transplantation: Methods and Outcomes (3 papers). Sullivan Km collaborates with scholars based in United States and South Africa. Sullivan Km's co-authors include Thomas Ed, Appelbaum Fr, CD Buckner, PL Weiden, Deeg Hj, Rainer Storb, JE Sanders, Shulman Hm, Nancy Flournoy and Sanders Je and has published in prestigious journals such as Transplantation Proceedings and PubMed.

In The Last Decade

Sullivan Km

20 papers receiving 665 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sullivan Km United States 14 555 220 196 115 102 20 707
Bengt Sallerfors Sweden 13 512 0.9× 171 0.8× 187 1.0× 80 0.7× 85 0.8× 25 776
Y Bonny Canada 15 328 0.6× 200 0.9× 89 0.5× 122 1.1× 76 0.7× 34 678
WE Beschorner United States 11 819 1.5× 317 1.4× 206 1.1× 189 1.6× 74 0.7× 13 998
V Altomonte United States 13 562 1.0× 302 1.4× 179 0.9× 145 1.3× 49 0.5× 15 781
E. Di Bona Italy 14 631 1.1× 142 0.6× 320 1.6× 70 0.6× 126 1.2× 21 973
Prentice Hg United Kingdom 14 354 0.6× 145 0.7× 177 0.9× 44 0.4× 74 0.7× 20 622
PS Stewart United States 6 888 1.6× 335 1.5× 227 1.2× 75 0.7× 52 0.5× 8 1.0k
S Dahlberg United States 10 836 1.5× 287 1.3× 191 1.0× 60 0.5× 58 0.6× 12 973
Michela Cerno Italy 14 372 0.7× 158 0.7× 234 1.2× 110 1.0× 64 0.6× 32 653
G. Santos United States 4 686 1.2× 184 0.8× 237 1.2× 66 0.6× 43 0.4× 6 798

Countries citing papers authored by Sullivan Km

Since Specialization
Citations

This map shows the geographic impact of Sullivan Km's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sullivan Km with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sullivan Km more than expected).

Fields of papers citing papers by Sullivan Km

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sullivan Km. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sullivan Km. The network helps show where Sullivan Km may publish in the future.

Co-authorship network of co-authors of Sullivan Km

This figure shows the co-authorship network connecting the top 25 collaborators of Sullivan Km. A scholar is included among the top collaborators of Sullivan Km based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sullivan Km. Sullivan Km is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Storb, Rainer, Wendy M. Leisenring, Claudio Anasetti, et al.. (1997). Methotrexate and cyclosporine for graft-vs.-host disease prevention: what length of therapy with cyclosporine?. PubMed. 3(4). 194–201. 25 indexed citations
2.
Km, Sullivan, et al.. (1996). Inositol 1,4,5-trisphosphate receptor activation and nuclear envelope assembly.. PubMed. 51. 189–93. 2 indexed citations
3.
Km, Sullivan, Jan Storek, Gary Longton, et al.. (1996). A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-vs.-host disease after marrow transplantation: clinical outcome and effect on subsequent immune recovery.. PubMed. 2(1). 44–53. 89 indexed citations
4.
Km, Sullivan, et al.. (1993). Fatal eosinophilia myalgia syndrome in a marrow transplant patient attributed to total parenteral nutrition with a solution containing tryptophan.. PubMed. 11(2). 163–7. 3 indexed citations
5.
Hj, Deeg, et al.. (1992). Photoinactivation of lymphohemopoietic cells: studies in transfusion medicine and bone marrow transplantation.. PubMed. 18(1). 151–61; discussion 161. 15 indexed citations
6.
Nemunaitis, John, Jack W. Singer, CD Buckner, et al.. (1991). Long-term follow-up of patients who received recombinant human granulocyte-macrophage colony stimulating factor after autologous bone marrow transplantation for lymphoid malignancy.. PubMed. 7(1). 49–52. 25 indexed citations
7.
Fr, Appelbaum, Petersen Fb, Fisher Ld, et al.. (1991). Busulfan and cyclophosphamide as a preparative regimen for bone marrow transplantation in patients with prior chest radiotherapy.. PubMed. 8(3). 211–5. 21 indexed citations
8.
Km, Sullivan, et al.. (1990). Cyclosporine treatment of chronic graft-versus-host disease following allogeneic bone marrow transplantation.. PubMed. 22(3). 1336–8. 10 indexed citations
9.
Km, Sullivan. (1989). Current status of bone marrow transplantation.. PubMed. 21(3 Suppl 1). 41–50. 10 indexed citations
10.
Km, Sullivan. (1989). Congress review: progress and prospects in bone marrow transplantation.. Transplantation Proceedings. 21(1 Pt 3). 2919–22. 6 indexed citations
11.
Fb, Petersen, CD Buckner, Appelbaum Fr, et al.. (1989). Busulfan, cyclophosphamide and fractionated total body irradiation as a preparatory regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I study.. PubMed. 10(1). 617–23. 43 indexed citations
12.
Km, Sullivan, CD Buckner, JE Sanders, et al.. (1989). Long-term complications of bone marrow transplantation.. PubMed. 309. 367–74. 1 indexed citations
13.
Hm, Shulman & Sullivan Km. (1988). Graft-versus-host disease: allo- and autoimmunity after bone marrow transplantation.. PubMed. 6. 141–65. 22 indexed citations
14.
Fb, Petersen, Mark Thornquist, Meyers Jd, et al.. (1987). The effect of prophylactic intravenous immune globulin on the incidence of septicemia in marrow transplant recipients.. PubMed. 2(2). 141–7. 35 indexed citations
15.
Km, Sullivan, A Fefer, Robert P. Witherspoon, et al.. (1987). Graft-versus-leukemia in man: relationship of acute and chronic graft-versus-host disease to relapse of acute leukemia following allogeneic bone marrow transplantation.. PubMed. 244. 391–9. 31 indexed citations
16.
Doney, K, Rainer Storb, CD Buckner, et al.. (1987). Treatment of aplastic anemia with antithymocyte globulin, high-dose corticosteroids, and androgens.. PubMed. 15(3). 239–42. 30 indexed citations
17.
Km, Sullivan, Rainer Storb, PL Weiden, et al.. (1986). Second marrow infusion for poor graft function after allogeneic marrow transplantation.. PubMed. 1(1). 21–30. 43 indexed citations
18.
Km, Sullivan, et al.. (1984). Rapidly progressive air-flow obstruction in marrow transplant recipients. Possible association between obliterative bronchiolitis and chronic graft-versus-host disease.. PubMed. 129(4). 641–4. 92 indexed citations
19.
Km, Sullivan, Deeg Hj, JE Sanders, et al.. (1984). Late complications after marrow transplantation.. PubMed. 21(1). 53–63. 104 indexed citations
20.
Weiden, PL, Nancy Flournoy, Sanders Je, Sullivan Km, & Thomas Ed. (1981). Antileukemic effect of graft-versus-host disease contributes to improved survival after allogeneic marrow transplantation.. PubMed. 13(1 Pt 1). 248–51. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026